@GroupBenefitsMG Excellent point!
RT @GroupBenefitsMG: @KipPiper @ShimCode Good to r…
posted on September 20, 2013 by
RT @GroupBenefitsMG: @KipPiper @ShimCode Good to recognize limitations (incl often overlooked network), but believe some ins exponentially > none, esp outside ER
RT @GroupBenefitsMG: @KipPiper Yes, and regional r…
posted on July 19, 2013 by
RT @GroupBenefitsMG: @KipPiper Yes, and regional robustness of networks crucial to assessment. Not an overriding value but of value that should be measurable 1/3
RT @GroupBenefitsMG: @brycewatch @cjrylands Much t…
posted on July 2, 2013 by
RT @GroupBenefitsMG: @brycewatch @cjrylands Much tbd but still pressure on plan sponsors: if 2014 ESI not affordable, hard to lure those subsidized back for 2015
RT @GroupBenefitsMG: Variance and opacity in gener…
posted on June 11, 2013 by
RT @GroupBenefitsMG: Variance and opacity in generic Rx pricing via @latimesbiz lat.ms/108hMV3
@GroupBenefitsMG Thanks, Dave! Very kind.
posted on May 31, 2013 by
@GroupBenefitsMG Thanks, Dave! Very kind.
@GroupBenefitsMG Thank you, kind sir.
posted on February 22, 2013 by
@GroupBenefitsMG Thank you, kind sir.
RT @GroupBenefitsMG: More excellent information fo…
posted on February 22, 2013 by
RT @GroupBenefitsMG: More excellent information for improving employee health via @WorldatWork and @heroehm ow.ly/hVzwS
